Identification of lead compound for medical inhibitor

Key benefits:The customer gained an understanding of what was the lead component used in its key competitor’s inhibitor coupled with relevant dosing regimen and dosing range/potency

Need

The customer wanted to know whether its key competitor’s two inhibitors were of the same generation in terms of their lead compounds. In addition, the customer wanted to know whether its other competitors had inhibitors in or close to clinical development.

Application: Product & Innovation Management

Geography: Germany

Approach

Analysis of information collected through relevant secondary sources, e.g. lists and blogs related to clinical trials, supported by selective expert interviews, with relevant clinical research institutes or freelancers working as Clinical Research Associates, as well as associations, physicians, and patients.

Methods: Secondary and primary research.

Solution

Within only three working days the customer received a report that revealed what was the previously unknown lead component used by their competitor.